127 related articles for article (PubMed ID: 7706765)
21. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells.
Fontanellas A; Mendez M; Mazurier F; Cario-André M; Navarro S; Ged C; Taine L; Géronimi F; Richard E; Moreau-Gaudry F; Enriquez De Salamanca R; de Verneuil H
Gene Ther; 2001 Apr; 8(8):618-26. PubMed ID: 11320408
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria.
Gouya L; Schneider-Yin X; Rüfenacht U; Herrero C; Lecha M; Mascaro JM; Puy H; Deybach JC; Minder EI
J Invest Dermatol; 1998 Sep; 111(3):406-9. PubMed ID: 9740232
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.
Frank J; Nelson J; Wang X; Yang L; Ahmad W; Lam H; Jugert FK; Kalka K; Poh-Fitzpatrick MB; Goerz G; Merk HF; Christiano AM
J Investig Med; 1999 Jul; 47(6):278-84. PubMed ID: 10431482
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
[TBL] [Abstract][Full Text] [Related]
25. A novel ferrochelatase gene mutation (IVS1-2 A-->C) in erythropoietic protoporphyria.
Lew W
J Invest Dermatol; 2003 Aug; 121(2):425-7. PubMed ID: 12880438
[No Abstract] [Full Text] [Related]
26. Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure.
Sarkany RP; Cox TM
QJM; 1995 Aug; 88(8):541-9. PubMed ID: 7648240
[TBL] [Abstract][Full Text] [Related]
27. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
[TBL] [Abstract][Full Text] [Related]
28. Examination of ferrochelatase mutations that cause erythropoietic protoporphyria.
Sellers VM; Dailey TA; Dailey HA
Blood; 1998 May; 91(10):3980-5. PubMed ID: 9573038
[TBL] [Abstract][Full Text] [Related]
29. Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.
Chen FP; Risheg H; Liu Y; Bloomer J
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):83-9. PubMed ID: 11929052
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria.
Sarkany RP; Whitcombe DM; Cox TM
J Invest Dermatol; 1994 Apr; 102(4):481-4. PubMed ID: 8151124
[TBL] [Abstract][Full Text] [Related]
31. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
Risheg H; Chen FP; Bloomer JR
Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietic protoporphyria: treatment with antioxidants and potential cure with gene therapy.
Mathews-Roth MM
Methods Enzymol; 2000; 319():479-84. PubMed ID: 10907535
[No Abstract] [Full Text] [Related]
33. Ferrochelatase.
Ferreira GC
Int J Biochem Cell Biol; 1999 Oct; 31(10):995-1000. PubMed ID: 10582332
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.
Schneider-Yin X; Gouya L; Dorsey M; Rüfenacht U; Deybach JC; Ferreira GC
Blood; 2000 Aug; 96(4):1545-9. PubMed ID: 10942404
[TBL] [Abstract][Full Text] [Related]
35. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.
Meerman L; Koopen NR; Bloks V; Van Goor H; Havinga R; Wolthers BG; Kramer W; Stengelin S; Müller M; Kuipers F; Jansen PL
Gastroenterology; 1999 Sep; 117(3):696-705. PubMed ID: 10464147
[TBL] [Abstract][Full Text] [Related]
36. Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene.
Nakahashi Y; Miyazaki H; Kadota Y; Naitoh Y; Inoue K; Yamamoto M; Hayashi N; Taketani S
Hum Mol Genet; 1993 Jul; 2(7):1069-70. PubMed ID: 8364548
[No Abstract] [Full Text] [Related]
37. Alteration of mRNA levels of delta-aminolevulinic acid synthase, ferrochelatase and heme oxygenase-1 in griseofulvin induced protoporphyria mice.
Inafuku K; Takamiyagi A; Oshiro M; Kinjo T; Nakashima Y; Nonaka S
J Dermatol Sci; 1999 Apr; 19(3):189-98. PubMed ID: 10215191
[TBL] [Abstract][Full Text] [Related]
38. A novel splicing mutation in the ferrochelatase gene responsible for erythropoietic protoporphyria.
Wang X; Poh-Fitzpatrick M; Piomelli S
Biochim Biophys Acta; 1994 Oct; 1227(1-2):25-7. PubMed ID: 7918679
[TBL] [Abstract][Full Text] [Related]
39. Screening for ferrochelatase mutations: molecular heterogeneity of erythropoietic protoporphyria.
Wang X; Poh-Fitzpatrick M; Taketani S; Chen T; Piomelli S
Biochim Biophys Acta; 1994 Jan; 1225(2):187-90. PubMed ID: 8280787
[TBL] [Abstract][Full Text] [Related]
40. A novel A(-4)-to-G acceptor splice site mutation leads to three bases insertion in ferrochelatase mRNA in a patient with erythropoietic protoporphyria.
Yotsumoto S; Shimada S; Terasaki K; Taketani S; Kobayashi K; Saheki T; Kanzaki T
J Invest Dermatol; 2001 Jul; 117(1):159-61. PubMed ID: 11442767
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]